Target Name: ZNF622
NCBI ID: G90441
Review Report on ZNF622 Target / Biomarker Content of Review Report on ZNF622 Target / Biomarker
ZNF622
Other Name(s): MGC2485 | zinc finger-like protein 9 | Zinc finger protein 622 | MGC17552 | Zinc finger-like protein 9 | Cytoplasmic 60S subunit biogenesis factor ZNF622 | zinc finger protein 622 | ZN622_HUMAN | ZPR9

ZNF622: A Protein Focus of Interest for Drug Targets and Biomarkers

ZNF622 (MGC2485) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZNF6 family, which includes several other proteins that are involved in the regulation of gene expression and cell signaling. ZNF622 has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF622 has become a focus of interest in the scientific community, with researchers studying its potential as a drug target or biomarker.

The ZNF622 protein is composed of 215 amino acid residues and has a calculated molecular mass of 24.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and has been shown to be involved in several cellular processes, including cell signaling, gene regulation, and inflammation.

One of the most significant functions of ZNF622 is its role in the regulation of gene expression. ZNF622 has been shown to interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3. These transcription factors are involved in the regulation of a wide range of cellular processes, including cell signaling, DNA replication, and gene expression. By interacting with these transcription factors, ZNF622 has the ability to influence the expression of genes that are important for the development and progression of various diseases.

In addition to its role in gene regulation, ZNF622 has also been shown to play a role in the regulation of cellular signaling pathways. ZNF622 has been shown to interact with several signaling proteins, including TGF-β1, FGF-1, and PDGF. These signaling proteins are involved in the regulation of cell growth, differentiation, and survival, and have been implicated in the development and progression of several diseases, including cancer. By interacting with these signaling proteins, ZNF622 has the ability to influence the signaling pathways that are important for the development and progression of these diseases.

Another function of ZNF622 is its role in the regulation of inflammation. ZNF622 has been shown to interact with several immune system proteins, including NF-kappa-B, ITGB3, and PDGF. These immune system proteins are involved in the regulation of inflammation, immune response, and tissue repair. As a result, ZNF622 has the ability to influence the immune system and contribute to the development and progression of inflammatory diseases.

In conclusion, ZNF622 is a protein that has been shown to play a number of roles in the regulation of gene expression, cellular signaling pathways, and inflammation. As a result, ZNF622 has become a focus of interest in the scientific community, with researchers studying its potential as a drug target or biomarker. Further research is needed to fully understand the functions of ZNF622 and its potential role in the development and progression of various diseases.

Protein Name: Zinc Finger Protein 622

Functions: Pre-60S-associated cytoplasmic factor involved in the cytoplasmic maturation of the 60S subunit

The "ZNF622 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF622 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740